Biomark Diagnostics Inc. (BMKDF)
OTCMKTS
· Delayed Price · Currency is USD
0.2399
-0.0201 (-7.73%)
Jul 9, 2025, 4:00 PM EDT
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.56K CAD in the quarter ending December 31, 2024, a decrease of -7.17%. This brings the company's revenue in the last twelve months to 155.03K, down -4.98% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
155.03K CAD
Revenue Growth
-4.98%
P/S Ratio
216.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.34M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 163.22K | 9.73K | 6.34% |
Mar 31, 2023 | 153.49K | 109.56K | 249.38% |
Mar 31, 2022 | 43.93K | - | - |
Mar 31, 2021 | - | - | - |
Mar 31, 2020 | 263.28K | - | - |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 84.04M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Biomark Diagnostics News
- 7 weeks ago - BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology - Newsfile Corp
- 2 months ago - BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test - Newsfile Corp
- 2 months ago - BioMark Diagnostics Announces Uplisting to OTCQB Venture Market - Newsfile Corp
- 3 months ago - BioMark Announces the Final Closing of Oversubscribed Private Placement - Newsfile Corp
- 4 months ago - BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 - Newsfile Corp
- 7 months ago - BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction - Newsfile Corp
- 8 months ago - BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection - Newsfile Corp
- 10 months ago - BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN - Newsfile Corp